Phong Phu Pharmaceutical JSC operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Phong Phu Pharmaceutical JSC with three other
pharmaceutical manufacturers in Asia:
Krebs Biochemicals & Industries Limited
sales of 477.58 million Indian Rupees [US$6.32 million]
Deccan Health Care Ltd
(442.48 million Indian Rupees [US$5.86 million]
of which 100%
was Fast moving consumer health products), and
Nova Wellness Group Bhd
based in MALAYSIA
(29.69 million Malaysian Ringgits [US$6.93 million]
During the year ended December of 2019, sales at
Phong Phu Pharmaceutical JSC were 151.11 billion Vietnamese Dong (US$6.51 million).
increase of 20.4%
versus 2018, when the company's sales were 125.53 billion Vietnamese Dong .